Verona pharma reports first quarter 2024 financial results and provides corporate update

Pdufa target action date for ensifentrine of june 26, 2024 finalizing commercial launch preparations strong balance sheet supports commercialization and pipeline expansion conference call today at 9:00 a.m. edt / 2:00 p.m.

VRNA Ratings Summary

VRNA Quant Ranking